Cheng-Wan Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cheng-Wan Li has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Feng-Lai Yuan
Department of Pediatrics, The Third Hospital Affiliated to Nantong University, Wuxi, Jiangsu, 214041, China
1 shared publicationHui-Ying Xu
Department of Pediatrics, The Third Hospital Affiliated to Nantong University, Wuxi, Jiangsu, 214041, China
1 shared publicationMing-Hui Xu
Department of Pediatrics, The Third Hospital Affiliated to Nantong University, Wuxi, Jiangsu, 214041, China
1 shared publicationShu-Jing Wang
Department of Pediatrics, The Third Hospital Affiliated to Nantong University, Wuxi, Jiangsu, 214041, China
1 shared publication- Xiao Tong
Affiliated Hospital of Jiangnan University, Wuxi, China
1 shared publication
Latest Publications
- 2 December 2016
- Published by Springer Nature in Inflammation
- Vol. 40 (1) , 324-327
Association of interleukin-18 and asthma
Cytokine-mediated immunity plays a dominant role in the pathogenesis of various immune diseases, including asthma. The recent identification of the family interleukin (IL)-1-related cytokine IL-18 now contributes to our understanding of the fine-tuning of cellular immunity. IL-18 can act as a cofactor for Th2 cell development and IgE production and also plays an important role in the differentiation of Th1 cells. Recent work identified an IL-18 association with the pathogenesis of asthma, wherein increased IL-18 expression was found in the serum of patients. Furthermore, IL-18 polymorphisms with susceptibility to asthma were reported, suggesting that IL-18 may be therapeutically relevant to asthma. In this review, we discuss the role of IL-18 in the pathogenesis of asthma and its therapeutic potential based on current research.
- 2 December 2016
- Published by Springer Nature in Inflammation
- Vol. 40 (1) , 324-327
Association of interleukin-18 and asthma
Cytokine-mediated immunity plays a dominant role in the pathogenesis of various immune diseases, including asthma. The recent identification of the family interleukin (IL)-1-related cytokine IL-18 now contributes to our understanding of the fine-tuning of cellular immunity. IL-18 can act as a cofactor for Th2 cell development and IgE production and also plays an important role in the differentiation of Th1 cells. Recent work identified an IL-18 association with the pathogenesis of asthma, wherein increased IL-18 expression was found in the serum of patients. Furthermore, IL-18 polymorphisms with susceptibility to asthma were reported, suggesting that IL-18 may be therapeutically relevant to asthma. In this review, we discuss the role of IL-18 in the pathogenesis of asthma and its therapeutic potential based on current research.